Antibiotic administration shortly before or after immunotherapy initiation is correlated with poor prognosis in solid cancer patients: An up-to-date systematic review and meta-analysis
- 1 November 2020
- journal article
- review article
- Published by Elsevier in International Immunopharmacology
- Vol. 88, 106876
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (81902422)
This publication has 54 references indexed in Scilit:
- Use of broad-spectrum antibiotics impacts outcome in patients treated with immune checkpoint inhibitorsOncoImmunology, 2018
- The Influence of the Gut Microbiome on Cancer, Immunity, and Cancer ImmunotherapyCancer Cell, 2018
- Negative association of antibiotics on clinical activity of immune checkpoint inhibitors in patients with advanced renal cell and non-small-cell lung cancerAnnals of Oncology, 2018
- Impact of antibiotic treatment on immune-checkpoint blockade efficacy in advanced non-squamous non-small cell lung cancerOncotarget, 2018
- Cancer immunotherapy using checkpoint blockadeScience, 2018
- Gut microbiome influences efficacy of PD-1–based immunotherapy against epithelial tumorsScience, 2018
- Gut microbiome modulates response to anti–PD-1 immunotherapy in melanoma patientsScience, 2018
- P1.07-008 Microbiome & Immunotherapy: Antibiotic Use Is Associated with Inferior Survival for Lung Cancer Patients Receiving PD-1 InhibitorsJournal of Thoracic Oncology, 2017
- Intestinal microbiome analyses identify melanoma patients at risk for checkpoint-blockade-induced colitisNature Communications, 2016
- Potential burden of antibiotic resistance on surgery and cancer chemotherapy antibiotic prophylaxis in the USA: a literature review and modelling studyThe Lancet Infectious Diseases, 2015